Concord Drugs (BOM:538965) YoY Rev. per Sh. Growth : -13.87% (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Concord Drugs YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Concord Drugs's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2024 was -13.87%.

Concord Drugs's Revenue per Share for the three months ended in Dec. 2024 was ₹10.96.

Concord Drugs YoY Rev. per Sh. Growth Historical Data

The historical data trend for Concord Drugs's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Drugs YoY Rev. per Sh. Growth Chart

Concord Drugs Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

YoY Rev. per Sh. Growth

Get a 7-Day Free Trial

-3.99

0.04

14.80

-17.08

-19.65

Concord Drugs Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
YoY Rev. per Sh. Growth	Get a 7-Day Free Trial															-17.85	40.49	32.40	41.90	-13.87

Concord Drugs YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Concord Drugs's YoY Rev. per Sh. Growth for the fiscal year that ended in Mar. 2024 is calculated as:

	YoY Rev. per Sh. Growth (A: Mar. 2024 )
=	(Revenue per Share (A: Mar. 2024 )	-	Revenue per Share (A: Mar. 2023 ))	/	\| Revenue per Share (A: Mar. 2023 ) \|
=	(44.925	-	55.91)	/	\| 55.91 \|
=	-19.65 %

Concord Drugs's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2024 is calculated as:

	YoY Rev. per Sh. Growth (Q: Dec. 2024 )
=	(Revenue per Share (Q: Dec. 2024 )	-	Revenue per Share (Q: Dec. 2023 ))	/	\| Revenue per Share (Q: Dec. 2023 )) \|
=	(10.956	-	12.72)	/	\| 12.72 \|
=	-13.87 %

Concord Drugs YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Concord Drugs's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Concord Drugs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Concord Drugs Ltd (BOM:538965) » Definitions » YoY Rev. per Sh. Growth

Traded in Other Exchanges

N/A

Address

Survey No. 249, Brahmanapally Village, Hayatnagar Mandal, Ranga Reddy, Hyderabad, TG, IND, 501511

Website

https://www.concorddrugs.in

Concord Drugs Ltd is an India based pharmaceutical company. The principal activity of the company is to manufacture licensed drugs based on the formulations approved. Its product portfolio includes Pharmaceutical Ready to fill Pellets, MUPS ((Multiple Unit Pellets System); Tissue Bio Adhesive; Injectables (Small Volume Parenterals); Capsules; Liquid Orals (Syrups & Suspensions); Dry Syrups (Powder) and Hand Sanitizers.

Concord Drugs Headlines

No Headlines